The Inflammation in the Cytopathology of Patients With Mucopolysaccharidoses- Immunomodulatory Drugs as an Approach to Therapy.

Anna Maria Wiesinger; Brian Bigger; Roberto Giugliani; Maurizio Scarpa; Tobias Moser; Christina Lampe; Christoph Kampmann; Florian Lagler

doi:10.3389/fphar.2022.863667

The Inflammation in the Cytopathology of Patients With Mucopolysaccharidoses- Immunomodulatory Drugs as an Approach to Therapy.

Anna Maria Wiesinger^* (First author), Brian Bigger, Roberto Giugliani, Maurizio Scarpa, Tobias Moser (Co-author), Christina Lampe, Christoph Kampmann, Florian Lagler (Last author)

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

10 Citations (Web of Science)

Original language	English
Pages (from-to)	863667
Journal	FRONTIERS IN PHARMACOLOGY
Volume	13
DOIs	https://doi.org/10.3389/fphar.2022.863667
Publication status	Published - 2022

Keywords

ENZYME REPLACEMENT THERAPY
LYSOSOMAL MEMBRANE PERMEABILIZATION
SULFATE DERIVED DISACCHARIDES
HEPARAN-SULFATE
MOUSE MODEL
OXIDATIVE STRESS
SANFILIPPO-SYNDROME
KERATAN SULFATE
MITOCHONDRIAL DYSFUNCTION
TARGETED DISRUPTION

Access to Document

10.3389/fphar.2022.863667

Cite this

@article{b30533373bec44c9931f6dac7483a5f1,

title = "The Inflammation in the Cytopathology of Patients With Mucopolysaccharidoses- Immunomodulatory Drugs as an Approach to Therapy.",

keywords = "ENZYME REPLACEMENT THERAPY, LYSOSOMAL MEMBRANE PERMEABILIZATION, SULFATE DERIVED DISACCHARIDES, HEPARAN-SULFATE, MOUSE MODEL, OXIDATIVE STRESS, SANFILIPPO-SYNDROME, KERATAN SULFATE, MITOCHONDRIAL DYSFUNCTION, TARGETED DISRUPTION",

author = "Wiesinger, {Anna Maria} and Brian Bigger and Roberto Giugliani and Maurizio Scarpa and Tobias Moser and Christina Lampe and Christoph Kampmann and Florian Lagler",

note = "Wiesinger, Lagler: Institute of Congenital Metabolic Diseases, Paracelsus Medical University, Salzburg, Austria; Moser: Department of Neurology, Christian Doppler University Hospital, Paracelsus Medical University, Salzburg, Austria",

year = "2022",

doi = "10.3389/fphar.2022.863667",

language = "English",

volume = "13",

pages = "863667",

journal = "FRONTIERS IN PHARMACOLOGY",

issn = "1663-9812",

publisher = "Frontiers Media Sa",

}

TY - JOUR

T1 - The Inflammation in the Cytopathology of Patients With Mucopolysaccharidoses- Immunomodulatory Drugs as an Approach to Therapy.

AU - Wiesinger, Anna Maria

AU - Bigger, Brian

AU - Giugliani, Roberto

AU - Scarpa, Maurizio

AU - Moser, Tobias

AU - Lampe, Christina

AU - Kampmann, Christoph

AU - Lagler, Florian

N1 - Wiesinger, Lagler: Institute of Congenital Metabolic Diseases, Paracelsus Medical University, Salzburg, Austria; Moser: Department of Neurology, Christian Doppler University Hospital, Paracelsus Medical University, Salzburg, Austria

PY - 2022

Y1 - 2022

KW - ENZYME REPLACEMENT THERAPY

KW - LYSOSOMAL MEMBRANE PERMEABILIZATION

KW - SULFATE DERIVED DISACCHARIDES

KW - HEPARAN-SULFATE

KW - MOUSE MODEL

KW - OXIDATIVE STRESS

KW - SANFILIPPO-SYNDROME

KW - KERATAN SULFATE

KW - MITOCHONDRIAL DYSFUNCTION

KW - TARGETED DISRUPTION

U2 - 10.3389/fphar.2022.863667

DO - 10.3389/fphar.2022.863667

M3 - Review article

C2 - 35645812

SN - 1663-9812

VL - 13

SP - 863667

JO - FRONTIERS IN PHARMACOLOGY

JF - FRONTIERS IN PHARMACOLOGY

ER -